Literature DB >> 21094619

Mechanisms of dynamic mechanical allodynia and dysesthesia in patients with peripheral and central neuropathic pain.

Åsa H Landerholm1, Per T Hansson.   

Abstract

Eighteen patients with peripheral neuropathic pain (PNeP) and seven patients with central post-stroke pain (CPSP) all suffering from dynamic mechanical allodynia (DMA) in a limb were studied. From recent research it is reasonable to suggest that A-beta fibres constitute the peripheral substrate for DMA in patients with PNeP. The pathophysiological basis for DMA in patients with CPSP is unknown. It is clinically observed that some patients with neuropathic pain report variable intensity of DMA and volunteer that the phenomenon at times is only an unpleasant, i.e., dysesthetic sensation. The pathophysiological basis for dynamic mechanical dysesthesia (DMD) has never been addressed. Based on the aforementioned clinical observations we aimed at investigating if DMA is the hyperbole of DMD both mediated by A-beta fibres in the periphery. A compression/ischemia-induced (differential) nerve block in conjunction with repeated quantitative sensory testing of A-delta and C-fibre function using cold and warm stimuli was used to assess which nerve fibre population that contributes to DMA and DMD, respectively. During the nerve block there was a transition of DMA to DMD in all patients with PNeP and in 3/7 patients with CPSP. The rest of the patients lost DMA without transition to DMD. The transition or loss of DMA without transition occurred early and concurrently in time during the block and was paralleled by a continuous impairment of mainly A-beta fibre function. We therefore suggest DMA to be the hyperbole of DMD, the difference being the number of mechanoreceptive fibres having access to the nociceptive system.
Copyright © 2010. Published by Elsevier Ltd.

Entities:  

Mesh:

Year:  2010        PMID: 21094619     DOI: 10.1016/j.ejpain.2010.10.003

Source DB:  PubMed          Journal:  Eur J Pain        ISSN: 1090-3801            Impact factor:   3.931


  10 in total

Review 1.  Reappraising neuropathic pain in humans--how symptoms help disclose mechanisms.

Authors:  Andrea Truini; Luis Garcia-Larrea; Giorgio Cruccu
Journal:  Nat Rev Neurol       Date:  2013-09-10       Impact factor: 42.937

2.  Assessment of pain response in capsaicin-induced dynamic mechanical allodynia using a novel and fully automated brushing device.

Authors:  Kristian Gaarn du Jardin; Lise Skøtt Gregersen; Turid Røsland; Kathrine Hebo Uggerhøj; Lars Jelstrup Petersen; Lars Arendt-Nielsen; Parisa Gazerani
Journal:  Pain Res Manag       Date:  2013 Jan-Feb       Impact factor: 3.037

3.  An investigation into the peripheral substrates involved in the tactile modulation of cutaneous pain with emphasis on the C-tactile fibres.

Authors:  David A Mahns; Saad S Nagi
Journal:  Exp Brain Res       Date:  2013-04-21       Impact factor: 1.972

4.  Distinct calcitonin gene-related peptide expression pattern in primary afferents contribute to different neuropathic symptoms following chronic constriction or crush injuries to the rat sciatic nerve.

Authors:  Yu Zou; Fangting Xu; Zhaohui Tang; Tao Zhong; Jiawei Cao; Qulian Guo; Changsheng Huang
Journal:  Mol Pain       Date:  2016 Jan-Dec       Impact factor: 3.395

Review 5.  Botulinum Toxin for Central Neuropathic Pain.

Authors:  Jihye Park; Myung Eun Chung
Journal:  Toxins (Basel)       Date:  2018-06-01       Impact factor: 4.546

Review 6.  Multifunctional Opioid-Derived Hybrids in Neuropathic Pain: Preclinical Evidence, Ideas and Challenges.

Authors:  Joanna Starnowska-Sokół; Barbara Przewłocka
Journal:  Molecules       Date:  2020-11-25       Impact factor: 4.411

7.  The prevalence and management of central post-stroke pain at a hospital in Zimbabwe.

Authors:  Caryn Tatenda Mhangara; Vaneshveri Naidoo; Mokgobadibe Veronica Ntsiea
Journal:  Malawi Med J       Date:  2020-09       Impact factor: 0.875

8.  The characteristics of pain and dysesthesia in patients with diabetic polyneuropathy.

Authors:  Sandra Sif Gylfadottir; Mustapha Itani; Alexander Gramm Kristensen; Pall Karlsson; Thomas Krøigård; David L Bennett; Hatice Tankisi; Niels Trolle Andersen; Troels Staehelin Jensen; Søren Hein Sindrup; Nanna Brix Finnerup
Journal:  PLoS One       Date:  2022-02-17       Impact factor: 3.240

9.  Recovery from nerve injury induced behavioral hypersensitivity in rats parallels resolution of abnormal primary sensory afferent signaling.

Authors:  M Danilo Boada; Thomas J Martin; Renee Parker; Timothy T Houle; James C Eisenach; Douglas G Ririe
Journal:  Pain       Date:  2020-05       Impact factor: 7.926

10.  Superiority of capsaicin 8% patch versus oral pregabalin on dynamic mechanical allodynia in patients with peripheral neuropathic pain.

Authors:  G Cruccu; T J Nurmikko; E Ernault; F K Riaz; W T McBride; M Haanpää
Journal:  Eur J Pain       Date:  2017-12-01       Impact factor: 3.931

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.